| Detected | Trial | Change |
|---|---|---|
| 2026-08-13 | NCT07746635 Fecal Microbiota Transplantation for Obese Women With Polyendocrine Metabolic Ovarian… |
Enrollment increased: 60 -> 161 participants |
| 2026-08-13 | NCT07746635 Fecal Microbiota Transplantation for Obese Women With Polyendocrine Metabolic Ovarian… |
Trial arms changed: 1 -> 2 |
| 2026-08-02 | NCT04278222 Anlotinib Plus Toripalimab as First-line Treatment for Advanced Gastric Cancer With ECOG… |
overall status: Recruiting → Unknown |
| 2026-07-24 | NCT06228404 Clinical Study of Safety and Efficacy of Enhanced PSMA CAR- T in Refractory CRPC |
date change Primary completion pushed: 2026-05 -> 2026-08 |
| 2026-07-24 | NCT06509919 Application of a Novel Model Based on Plasma cfDNA Assay and MRl Imaging in the Detection… |
critical Recruitment suspended |
| 2026-07-24 | NCT06509919 Application of a Novel Model Based on Plasma cfDNA Assay and MRl Imaging in the Detection… |
Enrollment increased: 1100 -> 1600 participants |
| 2026-07-24 | NCT06509919 Application of a Novel Model Based on Plasma cfDNA Assay and MRl Imaging in the Detection… |
Trial sites expanded: 1 -> 10 locations |
| 2026-07-24 | NCT06509919 Application of a Novel Model Based on Plasma cfDNA Assay and MRl Imaging in the Detection… |
date change Primary completion pushed: 2025-12 -> 2026-12 |
| 2026-07-24 | NCT06509919 Application of a Novel Model Based on Plasma cfDNA Assay and MRl Imaging in the Detection… |
date change Completion pushed: 2025-12 -> 2026-12 |
| 2026-07-24 | NCT06586658 Anti-CD70-CAR-T Cell Injection for the Treatment of Locally Advanced or… |
critical Recruitment suspended |
| 2026-07-24 | NCT06238713 Extraperitoneal SINgle-port rObotic-assisted Radical Prostatectomy (RARP) Versus… |
date change Primary completion pushed: 2025-06 -> 2028-06 |
| 2026-07-24 | NCT06238713 Extraperitoneal SINgle-port rObotic-assisted Radical Prostatectomy (RARP) Versus… |
date change Completion pushed: 2025-12 -> 2028-12 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-05 | NCT07746635 Fecal Microbiota Transplantation for Obese Women With Polyendocrine Metabolic Ovarian… | Recruiting | |
| 2026-07-21 | NCT07716397 Screening, Classification, and Outcome Prediction Ensemble Using Orbital MRI for Thyroid… | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07152340 | The Safety and Efficacy of Sequential Hormone Therapy and IBI311 Therapy in Patients With… | Thyroid Associated Ophthalmopathies | Recruiting |
| NCT07152366 | Efficacy and Safety of Sequential Hormone Therapy and Tetuzumab Therapy in Patients With… | Thyroid Associated Ophthalmopathies | Recruiting |
| NCT07152392 | Evaluation of the Efficacy and Safety Observation of IBI311 Treatment in Patients With… | Thyroid Associated Ophthalmopathies | Recruiting |
| Phase 2/3 | |||
| NCT06696248 | Carvedilol and Alverine in Portal Hypertension | Hypertension, Portal | Not Yet Recruiting |
| NCT06847178 | Efficacy and Safety of LC-Z300-01 in Chinese With Type 2 Diabetes | Diabetes | Not Yet Recruiting |
| Phase 2 | |||
| NCT06078969 | Oral Prednisone in Treating LCH of Bone in Childhood and Adolescence | Langerhans Cell Histiocytosis of Bone | Recruiting |
| NCT06603376 | Irinotecan Hydrochloride Liposome Injection (Ⅱ) Combined with Fluorouracil, Folinic Acid… | Colorectal Carcinoma | Recruiting |
| NCT05585814 | CapeOX Combined With Bevacizumab Plus Anti-PD1 Antibody as Neoadjuvant Therapy for… | Locally Advanced Colorectal Cancer | Recruiting |
| NCT06881537 | CapeOX Combined With Bevacizumab Plus Anti-PD1 Antibody as Neoadjuvant Therapy for… | Locally Recurrent Colorectal Cancer | Recruiting |
| NCT06930118 | The Aim of This Study is to Assess the Efficacy and Safety of Chidamide, Regorafenib in… | Advanced Colorectal Cancer in the Third-line Treatment and Beyond | Recruiting |
| NCT07398326 | Anlotinib Combined With Sintilimab as First-line Treatment for Advanced Non-liver… | Colorectal Cancer | Recruiting |
| NCT07652879 | KCD (Carfilzomib/Cyclophosphamide/Dexamethasone) Regimen for the Treatment of Newly… | POEMS Syndrome | Recruiting |
| NCT05508633 | The Instant Efficacy and Safety of Alverine in Decreasing Portal Hypertension: an… | Portal Hypertension | Enrolling by Invitation |
| NCT07621484 | HIPEC Priming Followed by Serplulimab Plus SOX/XELOX in Locally Advanced Gastric Cancer | Locally Advanced Gastric Cancer | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT07103980 | Inhaled Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Post-Infectious Cough… | Post-Infectious Cough | Recruiting |
| NCT07000292 | MSC303 Subcutaneous Injection for the Treatment of Immunologic Glomerular Disease. | Lupus Nephritis (LN) | Not Yet Recruiting |
| Phase 1 | |||
| NCT06895811 | Clinical Study of Safety and Efficacy of Universal PSMA CAR- T in Refractory CRPC | Metastatic Prostate Cancer | Active, Not Recruiting |
| Early Phase 1 | |||
| NCT06407947 | Study of CT071 Injection in High Risk Newly Diagnosed Multiple Myeloma | Multiple Myeloma | Recruiting |
| NCT06718270 | a Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Plasma… | Relapsed/Refractory Multiple Myeloma | Recruiting |
| NCT06418659 | A Clinical Trial Evaluating the Safety and Efficacy of Intravenous CD-801 in Treating… | Advanced Hepatocellular Carcinoma | Recruiting |
| NCT06583993 | A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α srRNA in… | Intrahepatic Cholangiocarcinoma | Recruiting |
| NCT06621173 | A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α SrRNA in… | Metastatic Colorectal Cancer (mCRC) | Recruiting |
| NCT07050394 | A Dose-Expansion Trial of Intravenous HNF4α srRNA for Unresectable or Metastatic… | Colorectal Cancer Metastatic | Recruiting |
| NCT07185932 | Efficacy and Safety of Rifaximin in Treating MAFLD | Metabolic-associated Fatty Liver Disease | Recruiting |
| NCT07314489 | A Study on the Changes of Glucose Metabolism and Exocrine Function in Patients With… | Chronic Pancreatitis Pancreatic Exocrine Insufficiency Blood Glucose | Recruiting |